Guanfacine Treatment of Comorbid Attention-Deficit Hyperactivity Disorder and Tourette's Syndrome: Preliminary Clinical Experience
- 1 September 1995
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 34 (9), 1140-1146
- https://doi.org/10.1097/00004583-199509000-00010
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Guanfacine as an alpha-2-agonist inducer of growth hormone secretion—a comparison with clonidinePsychoneuroendocrinology, 1993
- Pharmacologic Controversy of CNS Stimulants in Gilles de la Touretteʼs SyndromeClinical Neuropharmacology, 1992
- Study on the histamine-like activity of guanfacineJournal of Pharmacy and Pharmacology, 1990
- Clonidine and Gilles de la Tourette's syndrome: Double‐blind study using objective rating methodsAnnals of Neurology, 1987
- Clonidine Benefits Children with Attention Deficit Disorder and Hyperactivity: Report of a Double-Blind Placebo-Crossover Therapeutic TrialJournal of the American Academy of Child Psychiatry, 1985
- Gilles de la Tourette's syndromeNeurology, 1985
- Treatment approaches in Gilles de la Tourette syndromeBrain Research Bulletin, 1983
- CLONIDINE IN TOURETTE SYNDROMEThe Lancet, 1981
- CLONIDINE IN TOURETTE'S SYNDROMEThe Lancet, 1979
- Gilles de la Tourette's Syndrome following Methylphenidate AdministrationDevelopmental Medicine and Child Neurology, 1974